Ethanol and amino acids in the central nervous system: Assessment of the pharmacological actions of acamprosate

Progress in Neurobiology

Volumn 60, Issue 4, 2000, Pages 343-362

  Dahchour, A ^a   De Witte, P ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACAMPROSATE; ALCOHOL; AMINO ACID; GLUTAMIC ACID; NEUROTRANSMITTER; TAURINE;

ABSTINENCE; ALCOHOL INTOXICATION; ALCOHOL WITHDRAWAL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG MECHANISM; MICRODIALYSIS; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ALCOHOL DETERRENTS; ALCOHOL-INDUCED DISORDERS, NERVOUS SYSTEM; ALCOHOLISM; ANIMALS; ETHANOL; HUMANS; NEUROTRANSMITTER AGENTS; TAURINE;

EID: 0033990736     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(99)00031-3     Document Type: Review

References (248)

1. Adams M.L., Sewing B.N., Chen J., Meyer E.R., Cicero T.J. Nitric oxide-related agents alter alcohol withdrawal in male rats. Alcohol. clin. exp. Res. 19:1995;195-199.
2. Adinoff B., Kramer G.L., Petty F. Levels of gamma-aminobutyric acid in cerebrospinal fluid and plasma during alcohol withdrawal. Psychiat. Res. 59:1995;137-144.
3. - current in mouse hippocampal and cortical neurons. Eur. J. Pharmac. 187:1990;127-130.
4. Allan A.M., Harris R.A. Anesthetic and convulsant barbiturates alter gamma-aminobutyric acid-stimulated chloride flux across brain membranes. J. Pharmac. exp. Ther. 238:1986;763-768.
5. Allan A.M., Harris R.A. Acute and chronic ethanol treatments alter GABA receptor-operated chloride channels. Pharmac. Biochem. Behav. 27:1987;665-670.
6. +-induced calcium flux into cortical neurons in vitro. Alcohol. clin. exp. Res. 20:1996;92A.
7. alQatari M., Bouchenafa O., Littleton J. Mechanism of action of acamprosate. Part II: ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex. Alcohol. clin. exp. Res. 22:1998;810-814.
8. Aragon C.M., Amit Z. Taurine and ethanol-induced conditioned taste aversion. Pharmac. Biochem. Behav. 44:1993;263-266.
9. Aragon C.M., Trudeau L.E., Amit Z. Effect of taurine on ethanol-induced changes in open-field locomotor activity. Psychopharmac. Berl. 107:1992;337-340.
10. Aruoma O.I., Halliwell B., Hoey B.M., Butler J. The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem. J. 256:1988;251-255.
11. Becker H.C., Jarvis M.F. Chronic ethanol exposure selectively increases diazepam-insensitive [H-3]RO15-4513 binding in mouse cerebellum. Eur. J. Pharmac. 296:1996;43-46.
12. Berton F., Francesconi W.G., Madamba S.G., Zieglgansberger W., Siggins G.R. Acamprosate enhances N-methyl-D-apartate receptor-mediated neurotransmission but inhibits presynaptic GABA(B) receptors in nucleus accumbens neurons. Alcohol. clin. exp. Res. 22:1998;183-191.
13. Besson J., Aeby F., Kasas A., Lehert P., Potgieter A. Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study. Alcohol. clin. exp. Res. 22:1998;573-579.
14. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
15. Boggan W.O., Medberry C., Hopkins D.H. Effect of taurine on some pharmacological properties of ethanol. Pharmac. Biochem. Behav. 9:1978;469-472.
16. Boismare F., Daoust M., Moore N., Saligaut C., Lhuintre J.P., Chretien P., Durlach J. A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved? Pharmac. Biochem. Behav. 21:1984;787-789.
17. Bolo N., Nedelec J.F., Muzet M., De Witte Ph., Dahchour A., Durbin P., Macher J.P. Central effects of acamprosate: Part 2. Acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in healthy young male volunteers. Psychiat. Res. Neuroimag. 82:1998;115-127.
18. Bonhaus D.W., Huxtable R.J. The interaction of taurine and glutamate metabolism in brains of genetically seizure susceptible and seizure resistant rats. Proc. West. Pharmac. Soc. 28:1985;103-105.
19. Bowery N.G., Brown D.A. The cloning of GABA(B) receptors. Nature. 386:1997;223-224.
20. Bredt D.S., Snyder S.H. Nitric oxide: a physiologic messenger molecule. A. Rev. Biochem. 63:1994;175-195.
21. Buck K.J., Harris R.A. Neuroadaptive responses to chronic ethanol. Alcohol. clin. exp. Res. 15:1991;460-470.
22. Buck K.J., Hahner L., Sikela J., Harris R.A. Chronic ethanol treatment alters brain levels of gamma-aminobutyric acidA receptor subunit mRNAs: relationship to genetic differences in ethanol withdrawal seizure severity. J. Neurochem. 57:1991;1452-1455.
23. Bureau M.H., Olsen R.W. Taurine acts on subclass of GABAA receptors in mammalian brain in vitro. Eur. J. Pharmac. 207:1991;9-16.
24. Cantin A.M. Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro. Role of anion transport. J. clin. Invest. 93:1994;606-614.
25. Carboni S., Isola R., Gessa G.L., Rossetti Z.L. Ethanol prevents the glutamate release induced by N-methyl-D-aspartate in the rat striatum. Neurosci. Lett. 152:1993;133-136.
26. Chabenat C., Chretien P., Daoust M., Moore N., Andre D., Lhuintre J.P., Saligaut C., Boucly P., Boismare F. Physicochemical, pharmacological and pharmacokinetic study of a new GABAergic compound, calcium acetylhomotaurinate. Meth. Find. exp. clin. Pharmac. 10:1988;311-317.
27. Chandler L.G., Newson H., Sumner C., Crews F. Chronic ethanol exposure potentiates NMDA excitotoxicity in cerebral cortical neurons. J. Neurochem. 60:1993;1578-1581.
28. Chandler L.J., Sumners C., Crews F.T. Ethanol inhibits NMDA receptor-mediated excitotoxicity in rat primary neuronal cultures. Alcohol. clin. exp. Res. 17:1993;54-60.
29. Chandler L.J., Sutton G., Norwood D., Sumners C., Crews F.T. Chronic ethanol increases N-methyl-D-aspartate-stimulated nitric oxide formation but not receptor density in cultured cortical neurons. Mol. Pharmac. 51:1997;733-740.
30. Charlton M.E., Sweetnam P.M., Fitzgerald T.W., Terwilliger R.Z., Nestler E.J., Duman R.S. Chronic ethanol administration regulates the expression of GABA(A) receptor alpha(1) and alpha(5) subunits in the ventral tegmental area and hippocampus. J. Neurochem. 68:1997;121-127.
31. Chen X., Michaelis M.L., Michaelis E.K. Effects of chronic ethanol treatment on the expression of calcium transport carriers and NMDA/glutamate receptor proteins in brain synaptic membranes. J. Neurochem. 69:1997;1559-1569.
32. Choi D.W. Glutamate neurotoxicity and disease of the nervous system. Neuron. 1:1988;623-634.
33. Choi D.W. Excitotoxic cell death. J. Neurobiol. 23:1992;1261-1276.
34. Chovan J.P., Kulakowski E.C., Benson B.W., Schaffer S.W. Taurine enhancement of calcium binding to rat heart sarcolemma. Biochim. Biophys. Acta. 551:1979;129-135.
35. Chovan J.P., Kulakowski E.C., Sheakowski S., Schaffer S.W. Calcium regulation by the low-affinity taurine binding sites of cardiac sarcolemma. Molec. Pharmac. 17:1980;295-300.
36. Coan E.J., Saywood W., Collingridge G.L. MK-801 blocks NMDA receptor-mediated synaptic transmission and long term potentiation in rat hippocampal slices. Neurosci. Lett. 80:1987;111-114.
37. Collingridge G.L., Lester R.A. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmac. Rev. 41:1989;143-210.
38. Colombo G., Agabio R., Lobina C., Reali R., Melis F., Fadda F., Gessa G.L. Effects of the calcium channel antagonist darodipine on ethanol withdrawal in rats. Alcohol Alcohol. 30:1995;125-131.
39. Curtis D.R. GABA synapses in the brain. Trends Neurosci. 18:1995;263.
40. Dahchour, A., 1998. Ethanol effects on neuro-excitatory and neuro-inhibitory amino acids in rats: brain microdialysis study. UCL-BIOL-BANI, Ph.D. Dissertation (Ref. No. B 2 31 801J).
41. Dahchour A., De Witte Ph. Glutamate increases in the nucleus accumbens dialysate during ethanol withdrawal. Alcohol. clin. exp. Res. 16:1996;6A.
42. Dahchour A., De Witte Ph. Effect of repeated ethanol withdrawal on microdialysate glutamate release in the hippocampus. Alcohol. clin. exp. Res. 22:(A109):1998;175.
43. Dahchour A., De Witte Ph. Acamprosate decrease the hypermotility during repeated ethanol withdrawal. Alcohol. 18:1999;77-81.
44. Dahchour, A., De Witte, Ph., 1999b. Taurine blocks the glutamate increase in the nucleus accumbens microdialysat during ethanol withdrawn rats. Pharmac. Biochem. Behav. (in press).
45. Dahchour A., Quertemont E., De Witte Ph. Acute ethanol increases taurine but neither glutamate nor GABA in the nucleus accumbens of male rats: a microdialysis study. Alcohol. Alcohol. 29:1994;485-487.
46. Dahchour A., Durbin P., De Witte Ph. Ethanol and acamprosate increase the extracellular taurine in the nucleus accumbens: a microdialysis study. Alcohol Alcohol. 30:1995;483.
47. Dahchour A., Quertemont E., De Witte Ph. Taurine increases in the nucleus accumbens microdialysate after acute ethanol administration to naive and chronically alcoholised rats. Brain Res. 735:1996;9-19.
48. Dahchour A., De Witte Ph., Bolo N., Nedelec J.F., Muzet M., Durbin P., Macher J.P. Central effects of acamprosate: Part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiat. Res. Neuroimag. 82:1998;107-114.
49. Daoust M., Legrand E., Gewiss M., Heidbreder C., De Witte Ph., Tran G., Durbin Ph. Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats. Pharmac. Biochem. Behav. 41:1992;669-674.
50. Davidson M., Shanley B., Wilce P. Increased NMDA-induced excitability during ethanol withdrawal: a behavioural and histological study. Brain Res. 674:1995;91-96.
51. Davison N.A., Kaczmarek L.N. Taurine: a possible neurotransmitter? Nature. 234:1971;107-108.
52. Deitrich R.A., Dunwiddie T.V., Harris R.A., Erwin V.G. Mechanism of action of ethanol: initial central nervous system actions. Pharmac. Rev. 41:1989;489-536.
53. Devaud L.L., Purdy R.H., Morrow A.L. The neurosteroid, 3 alpha-hydroxy-5 alpha-pregnan-20-one, protects against bicuculline-induced seizures during ethanol withdrawal in rats. Alcohol. clin. exp. Res. 19:1995;350-355.
54. Devaud L.L., Purdy R.H., Finn D.A., Morrow A.L. Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal. J. Pharmac. exp. Ther. 278:1996;510-517.
55. Devaud L.L., Fritschy J.M., Sieghart W., Morrow A.L. Bidirectional alterations of GABA(A) receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal. J. Neurochem. 69:1997;126-130.
56. 2+ in dissociated brain cells. Brain Res. 499:1989;383-387.
57. Dildy Mayfield J.E., Harris R.A. Acute and chronic ethanol exposure alters the function of hippocampal kainate receptors expressed in Xenopus oocytes. J. Neurochem. a58:1992;1569-1572.
58. Dildy Mayfield J.E., Harris R.A. Comparison of ethanol sensitivity of rat brain kainate, DL-alpha-amino-3-hydroxy-5-methyl-4-isoxalone proprionic acid and N-methyl-D-aspartate receptors expressed in Xenopus oocytes. J. Pharmac. exp. Ther. b262:1992;487-494.
59. Dingledine R., Hynes M.A., King G.L. Involvement of N-methyl-D-aspartate receptors in epileptiform bursting in the rat hippocampal slice. J. Physiol. Lond. 380:1986;175-189.
60. Dolphin A.C. G protein modulation of calcium currents in neurons. A. Rev. Physiol. 52:1990;243-255.
61. - fluxes in rat brain synaptoneurosomes. J. Neurochem. 57:1991;384-390.
62. Faingold C.L., Ngouemo P., Riaz A. Ethanol and neurotransmitter interactions - from molecular to integrative effects. Prog. Neurobiol. 55:1998;509-535.
63. Ferko A.P. Ethanol-induced sleep time: interaction with taurine and a taurine antagonist. Pharmac. Biochem. Behav. 27:1987;235-238.
64. Ferko A.P., Bobyock E. Effect of taurine on ethanol-induced sleep time in mice genetically bred for differences in ethanol sensitivity. Pharmac. Biochem. Behav. 31:1988;667-673.
65. File S.E., Zharkovsky A., Hitchcott P.K. Effects of nitrendipine, chlordiazepoxide, flumazenil and baclofen on the increased anxiety resulting from alcohol withdrawal. Prog. Neuropsychopharmacol. Biol. Psychiatry. 16:1992;87-93.
66. Follesa P., Ticku M.K. Chronic ethanol treatment differentially regulates NMDA receptor subunit mRNA expression in rat brain. Molec. Brain Res. 29:1995;99-106.
67. French E.D., Vezzani A., Whetsell W.O. Jr., Schwarcz R. Anti-excitotoxic actions of taurine in the rat hippocampus studied in vivo and in vitro. Adv. exp. Med. Biol. 203:1986;349-362.
68. + channels by GABA. Trends Neurosci. 15:1992;46-51.
69. Gerra G., Giucasto G., Zaimovic A., Fertonani G., Chittolini B., Avanzini P., Caccavari R., Delsignore R. Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal. Int. clin. Psychopharmac. 11:1996;81-88.
70. Gewiss M., Heidbreder C., Opsomer L., Durbin P., De Witte Ph. Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol Alcohol. 26:1991;129-137.
71. Grant K.A., Woolverton W.L. Reinforcing and discriminative stimulus effects of Ca-acetyl homotaurine in animals. Pharmac. Biochem. Behav. 32:1989;607-611.
72. Grant K.A., Valverius P., Hudspith M., Tabakoff B. Ethanol withdrawal seizures and the NMDA receptor complex. Eur. J. Pharmac. 176:1990;289-296.
73. Grant S.G., O'Dell T.J., Karl K.A., Stein P.L., Soriano P., Kandel E.R. Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science. 258:1992;1903-1910.
74. Gulya K., Grant K.A., Valverius P., Hoffman P.L., Tabakoff B. Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Res. 547:1991;129-134.
75. Haas H.L., Hosli L. The depression of brain stem neurones by taurine and its interaction with strychnine and bicuculline. Brain Res. 52:1973;399-402.
76. Hanretta A.T., Lombardini J.B. Properties of spontaneous and evoked release of taurine from hypothalamic crude P2 synaptosomal preparations. Brain Res. 378:1986;205-215.
77. Heyser C.J., Schulteis G., Durbin P., Koob G.F. Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology. 18:1998;125-133.
78. Hillemand B., Lhuintre J.P., Boismare F. Premier-essai favorable du N-bsacetyl-homotaurinate du calcium dans le traitement de líalcoolo-dependants. Rev. Alcool. 30:1984;204-212.
79. Hillemand B., Lhuintre J.P., Steru L., Boismare F., Daoust M., Moore N. Essai thèrapeutique multicentrique du N-bsacetyl-homotaurinate du calcium dand le traitement díalcoolo-dèpendants. Rev. Alcool. 34:1989;9-28.
80. Hoffman P.L. Glutamate receptors in alcohol withdrawal-induced neurotoxicity. Metab. Brain Dis. 10:1995;73-79.
81. Hoffman P.L., Tabakoff B. The role of the NMDA receptor in ethanol withdrawal. Ex. 71:1994;61-70.
82. Hoffman P.L., Moses F., Tabakoff B. Selective inhibition by ethanol of glutamate-stimulated cyclic GMP production in primary cultures of cerebellar granule cells. Neuropharmacology. 28:1989;1239-1243.
83. Hoffman P.L., Rabe C.S., Moses F., Tabakoff B. N-Methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. J. Neurochem. 52:1989;1937-1940.
84. Hollmann M., Maron C., Heinemann S. N-glycosylation site tagging suggests a three transmembrane domain topology for the glutamate receptor GluR1. Neuron. 13:1994;1331-1343.
85. Holter S.M., Landgraf R., Zieglgansberger W., Spanagel R. Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation. Alcohol clin. exp. Res. 21:1997;862-868.
86. Hu X.J., Follesa P., Ticku M.K. Chronic ethanol treatment produces a selective upregulation of the NMDA receptor subunit gene expression in mammalian cultured cortical neurons. Molec. Brain Res. 36:1996;211-218.
87. Huxtable R.J. From heart to hypothesis: a mechanism for the calcium modulatory actions of taurine. Adv. exp. Med. Biol. 217:1987;371-387.
88. Huxtable R.J. Taurine in the central nervous system and the mammalian actions of taurine. Prog. Neurobiol. 32:1989;471-533.
89. Huxtable R.J. Physiological actions of taurine. Physiol. Rev. 72:1992;101-163.
90. Huxtable R.J., Laird H., Bonhaus D., Thies A.C. Correlation between amino acid concentrations in brain of seizure-susceptibile and seizure-resistant rats. Neurochem. Int. 4:1982;73-78.
91. Iorio K.R., Tabakoff B., Hoffman P.L. Glutamate-induced neurotoxicity is increased in cerebellar granule cells exposed chronically to ethanol. Eur. J. Pharmac. 248:1993;209-212.
92. Kalluri H.S., Mehta A.K., Ticku M.K. Up-regulation of NMDA receptor subunits in rat brain following chronic ethanol treatment. Molec. Brain Res. 58:1998;221-224.
93. Kerr D.I., Ong J. GABAB receptors. Pharmac. Ther. 67:1995;187-246.
94. Kimelberg H.K., Goderie S.K., Higman S., Pang S., Waniewski R.A. Swelling-induced release of glutamate, aspartate, and taurine from astrocyte cultures. J. Neurosci. 10:1990;1583-1591.
95. Kimelberg H.K., Cheema M., OíConnor E.R., Tong H., Goderie S.K., Rossman P.A. Ethanol-induced aspartate and taurine release from primary astrocyte cultures. J. Neurochem. 60:1993;1682-1689.
96. Kokka N., Sapp D.W., Taylor A.M., Olsen R.W. The kindling model of alcohol dependence: similar persistent reduction in seizure threshold to pentylenetetrazol in animals receiving chronic ethanol or chronic pentylenetetrazol. Alcohol. clin. exp. Res. 17:1993;525-531.
97. Kontro P. Interactions of taurine and dopamine in the striatum. Adv. exp. Med. Biol. 217:1987;347-355.
98. Kontro P., Oja S.S. Release of taurine, GABA and dopamine from rat striatal slices: mutual interactions and developmental aspects. Neuroscience. 24:1988;49-58.
99. Kontro P., Oja S.S. Interactions of taurine with GABAB binding sites in mouse brain. Neuropharmacology. 29:1990;243-247.
100. B receptors in the brain. Prog. clin. Biol. Res. 351:1990;83-94.
101. Korpi E.R., Seeburg P.H. Natural mutation of GABAA receptor alpha 6 subunit alters benzodiazepine affinity but not allosteric GABA effects. Eur. J. Pharmac. 247:1993;23-27.
102. Kratzer U., Schmidt W.J. The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats. Neurosci. Lett. 252:1998;53-56.
103. Krnjevic K. Some neuroactive compounds in the substantia nigra. Adv. Neurol. 5:1974;145-152.
104. Krnjevic K. Role of GABA in cerebral cortex. Can. J. Physiol. Pharmac. 75:1997;439-451.
105. Kulakowski E.C., Maturo J., Schaffer S.W. Solubilization and characterization of cardiac sarcolemmal taurine-binding proteins. Arch. Biochem. Biophys. 210:1981;204-209.
106. Kurachi M., Yochihara K., Aihara H. Effect of taurine on depolarization induced L-glutamate and other excitatory amino acids in the isolated spinal cord of frog. Jap. J. Pharmac. 33:1983;1247-1254.
107. Ladewig D., Knecht T., Leher P., Fendl A. Acamprosate-a stabilizing factor in long-term withdrawal of alcoholic patients. Ther. Umsch. 50:1993;182-188.
108. Le Magnen J., Tran G., Durlach J., Martin C. Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by calcium acetyl homotaurinate. Alcohol. 4:1987;97-102.
109. Lehmann A., Isacsson H., Hamberger A. Effects of in vivo administration of kainic acid on the extracellular amino acid pool in the rabbit hippocampus. J. Neurochem. 40:1983;1314-1320.
110. Lehmann A., Lazarewicz J.W., Zeise M. N-Methylaspartate-evoked liberation of taurine and phosphoethanolamine in vivo: site of release. J. Neurochem. 45:1985;1172-1177.
111. Lhuintre J.P., Daoust M., Moore N.D., Chretien P., Saligaut C., Tran G., Boismare F., Hillemand B. Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics. Lancet. 1:1985;1014-1016.
112. Lhuintre J.P., Moore N., Tran G., Steru L., Langrenon S., Daoust M., Parot P., Ladure P., Libert C., Boismare F., et al. camprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol Alcohol. 25:1990;613-622.
113. Li Y.P., Lombardini J.B. Inhibition by taurine of the phosphorylation of specific synaptosomal proteins in the rat cortex: effects of taurine on the stimulation of calcium uptake in mitochondria and inhibition of phosphoinositide turnover. Brain Res. 553:1991;89-96.
114. Liljequist S. The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures. Eur. J. Pharmac. 192:1991;197-198.
115. Lim L., al Qatari M., Littleton J.M. Interactions between acamprosate and ethanol in vitro and ex vivo on calcium flux in rat brain slices. Alcohol. clin. exp. Res. 20:1996;92.
116. Litten R.Z., Allen J., Fertig J. Pharmacotherapies for alcohol problems: a review of research with focus on developments since, 1991. Alcohol. clin. exp. Res. 20:1996;859-876.
117. Littleton J. Acamprosate in alcohol dependence: how does it work? Addiction. 90:1995;1179-1188.
118. Littleton J., Little H. Current concepts of ethanol dependence. Addiction. 89:1994;1397-1412.
119. Littleton J.M., Dunnage J., Pagonis C. Kuriama K., Takada A., Ishii H. Alcohol Dependence and Modulation of Calcium Channels in Biomedical and Social Aspects of Alcohol and Alcoholism. 1988;Elsevier, Amsterdam.
120. Littleton J.M., Little H.J., Whittington M.A. Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal, doses required, stereo specificity and actions of Bay K 8644. Psychopharmacology. 100:1990;387-392.
121. Lombardini J.B. Regional and subcellular studies on taurine in the rat cerebral nervous systems. Huxtable R.J., Barbeau A. Taurine. 1976;311 Raven Press, New York.
122. Lombardini J.B. Effects of taurine on the phosphorylation of specific proteins in subcellular fractions of the rat retina. Neurochem. Res. 17:1992;821-824.
123. Lovinger D.M. High ethanol sensitivity of recombinant AMPA-type glutamate receptors expressed in mammalian cells. Neurosci. Lett. 159:1993;83-87.
124. Lovinger D.M., White G., Weight F.F. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science. 243:1989;1721-1724.
125. Lovinger D.M., White G., Weight F.F. Ethanol inhibition of neuronal glutamate receptor function. Ann. Med. 22:1990;247-252.
126. Madamba S.G., Schweitzer P., Zieglgansberger W., Siggins G.R. Acamprosate (calcium acetylhomotaurinate) enhances the N-methyl-D-aspartate component of excitatory neurotransmission in rat hippocampal CA1 neurons in vitro. Alcohol. clin. exp. Res. 20:1996;651-658.
127. Mahmoudi M., Kang M.H., Tillakaratne N., Tobin A.J., Olsen R.W. Chronic intermittent ethanol treatment in rats increases GABA(A) receptor alpha4-subunit expression: possible relevance to alcohol dependence. J. Neurochem. 68:1997;2485-2492.
128. Malcangio M., Bowery N.G. Possible therapeutic application of GABAB receptor agonists and antagonists. Clin. Neuropharmac. 18:1995;285-305.
129. Malminen O., Kontro P. Modulation of the GABA-benzodiazepine receptor complex by taurine in rat brain membranes. Neurochem. Res. 11:1986;85-94.
130. Maren S., Baudry M. Properties and mechanisms of long-term synaptic plasticity in the mammalian brain: relationships to learning and memory. Neurobiol. Learn. Mem. 63:1995;1-18.
131. Mattucci Schiavone L., Ferko A.P. Acute effects of taurine and a taurine antagonist on ethanol-induced central nervous system depression. Eur. J. Pharmac. 113:1985;275-278.
132. McBroom M.J., Elkhawad A.O., Dlouha H. Taurine and ethanol-induced sleeping time in mice: route and time course effects. Gen. Pharmac. 17:1986;97-100.
133. McKernan R.M., Whiting P.J. Which GABA receptors subtypes really occur in the brain? Trends Neurosci. 19:1996;139-143.
134. Mc Quilkin S.J., Harris R.A. Factors affecting actions of ethanol on GABA-activated chloride channels. Life Sci. 46:1990;527-541.
135. Medina J.H., De Robertis E. Taurine modulation of the benzodiazepine-gamma-aminobutyric acid receptor complex in brain membranes. J. Neurochem. 42:1984;1212-1217.
136. Mehta A.K., Ticku M.K. Developmental aspects of benzodiazepine receptors and GABA-gated chloride channels in primary cultures of spinal cord neurons. Brain Res. 454:1988;156-163.
137. Mehta A.K., Ticku M.K. Chronic GABA exposure down-regulates GABA-benzodiazepine receptor-ionophore complex in cultured cerebral cortical neurons. Molec. Brain Res. 16:1992;29-36.
138. Menendez N., Herreras O., Solis J.M., Sanchez Herranz A., Martin del Rio R. Extracellular taurine increase in rat hippocampus evoked by specific glutamate receptor activation is related to the excitatory potency of glutamate agonists. Neurosci. Lett. 102:1989;64-69.
139. Menendez N., Solis J.M., Herreras O., Sanchez Herranz A., Martin del Rio R. Role of endogenous taurine on the glutamate analogue-induced neurotoxicity in the rat hippocampus in vivo. J. Neurochem. 55:1990;714-717.
140. Michaelis E.K., Freed W.J., Galton N., Foye J., Michaelis M.L., Phillips I., Kleinman J.E. Glutamate receptor changes in brain synaptic membranes from human alcoholics. Neurochem. Res. 15:1990;1055-1063.
141. Mihic S.J., Harris R.A. Alcohol actions at the GABA(A) receptor/chloride channel complex. Deitrich R.A., Erwin V.G. Pharmacological Effects of Ethanol on the Nervous System. 1996;51-72 CRC Press, Boca Raton.
142. Mihic S.J., Wu P.H., Kalant H. Differences among effects of sedative-hypnotic drugs on GABA-mediated chloride flux: quench flow studies. Brain Res. 555:1991;259-264.
143. Moghaddam B., Bolinao M.L. Biphasic effect of ethanol on extracellular accumulation of glutamate in the hippocampus and the nucleus accumbens. Neurosci. Lett. 178:1994;99-102.
144. Mollemann A., Little H.J. Increased hippocampal calcium currents during withdrawal from chronic ethanol treatment. Br. J. Pharmac. 120:1997;371.
145. Montpied P., Morrow A.L., Karanian J.W., Ginns E.I., Martin B.M., Paul S.M. Prolonged ethanol inhalation decreases gamma-aminobutyric acid receptor a subunit mRNAs in the rat cerebral cortex. Molec. Pharmac. 39:1991;157-163.
146. Morgan P.F., Linnoila M. Regional induction of c-fos mRNA by NMDA: a quantitative in-situ hybridization study. Neuroreport. 2:1991;251-254.
147. Morgan P.F., Nadi N.S., Karanian J., Linnoila M. Mapping rat brain structures activated during ethanol withdrawal: role of glutamate and NMDA receptors. Eur. J. Pharmac. 225:1992;217-223.
148. Morrisett R.A., Swartzwelder H.S. Attenuation of hippocampal long-term potentiation by ethanol: a patch-clamp analysis of glutamatergic and GABAergic mechanisms. J. Neurosci. 13:1993;2264-2272.
149. A receptor function and gene expression in the central nervous system. Bradley R.J., Harris R.A. International Review of Neurobiology. 1995;1-14 Academic Press, New York.
150. Morrow A.L., Suzdak P.D., Paul S.M. Benzodiazepine, barbiturate, ethanol and hypnotic steroid hormone modulation of GABA-mediated chloride ion transport in rat brain synaptoneurosomes. Adv. Biochem. Psychopharmac. 45:1988;247-261.
151. A receptor function and expression in brain. Alcohol. 7:1990;237-244.
152. A receptor a1 and a6 subunit mRNA levels in rat cerebellum. J. Molec. cell. Neurosci. 3:1992;251-258.
153. Morton B., Ripley T.L., Whittington M.A., Butterworth A.R., Little H.J. Evidence that changes in hippocampal excitability in vitro are caused by withdrawal from chronic in vivo ethanol administration. Alcohol Alcohol. 27:1992;71-79.
154. Naassila M., Hammoumi S., Legrand E., Durbin P., Daoust M. Mechanism of action of acamprosate. Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain. Alcohol. clin. exp. Res. 22:1998;802-809.
155. Nakada T., Hida K., Kweel I.L. Brain pH and lactic acidosis: quantitative analysis of taurine effect. Neurosci. Res. 15:1992;115-123.
156. Nakamori K., Koyama I., Nakamura T., Yoshida T., Umeda M., Inoue K. Effectiveness of taurine in protecting biomembrane against oxidant. Chem. Pharm. Bull. Tokyo. 38:1990;3116-3119.
157. Nakamori K., Koyama I., Nakamura T., Nemoto M., Yoshida T., Umeda M., Inoue K. Quantitative evaluation of the effectiveness of taurine in protecting the ocular surface against oxidant. Chem. Pharm. Bull. Tokyo. 41:1993;335-338.
158. Nakanishi T., Takamitsu Y., Sugita M. Role of taurine in the kidney: osmoregulatory taurine accumulation in renal medulla. Adv. exp. Med. Biol. 359:1994;139-148.
159. Nalpas B., Dabadie H., Parot P., Paccalin J. Acamprosate. From pharmacology to therapeutics. Encephale. 16:1990;175-179.
160. Nestoros J.N. Ethanol selectively potentiates GABA-mediated inhibition of single feline cortical neurons. Life Sci. 26:1980;519-523.
161. Nicoll R.A., Malenka R.C., Kauer J.A. Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system. Physiol. Rev. 70:1990;513-665.
162. Nishikawa M., Hirouchi M., Kuriyama K. Functional coupling of Gi subtype with GABAB receptor/adenylyl cyclase system: analysis using a reconstituted system with purified GTP-binding protein from bovine cerebral cortex. Neurochem. Int. 31:1997;21-25.
163. Nishio M., Narahashi T. Ethanol enhancement of GABA-activated chloride current in rat dorsal root ganglion neurons. Brain Res. 518:1990;283-286.
164. Nutt D., Glue P., Wilson S., Groves S., Coupland N., Bailey J. Flumazenil in alcohol withdrawal. Alcohol Alcohol. 2:(suppl.):1993;337-341.
165. Obyrne M., Tipton K., Mc Bean G., Kollegger H. Assessment of neurotoxicity and 'neuroprotection'. J. Neural. Transmission. 50:(suppl.):1997;153-164.
166. Oja S.S., Kontro P. Taurine. Lajtha A. Handbook of Neurochemistry. 1983;501-533 Plenum Press, New York.
167. Oja S.S., Saransaari P. Cell volume changes and taurine release in cerebral cortical slices. Adv. exp. Med. Biol. 315:1992;369-374.
168. Oja S.S., Saransaari P. Relations of taurine release and influx to cell volumes in cerebral cortical slices. Huxtable R.J., Michalk D. Taurine in Health and Disease. 1994;269-277 Plenum Press, New York.
169. Oja S.S., Saransaari P. Taurine as osmoregulator and neuromodulator in the brain. Metab. Brain Dis. 11:1996;153-164.
170. Oja S.S., Korpi E.R., Saransaari P. Modification of chloride flux across brain membranes by inhibitory amino acids in developing and adult mice. Neurochem. Res. 15:1990;797-804.
171. Olsen R.W. GABA-benzodiazepine-barbiturate receptor interactions. J. Neurochem. 37:1981;1-13.
172. Ortiz J., Fitzgerald L.W., Charlton M., Lane S., Trevisan L., Guitart X., Shoemaker W., Duman R.S., Nestler E.J. Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse. 21:1995;289-298.
173. Osmanovic S.S., Shefner S.A. Enhancement of current induced by superfusion of GABA in locus coeruleus neurons by pentobarbital, but not ethanol. Brain Res. 517:1990;324-329.
174. Paille F.M., Guelfi J.D., Perkins A.C., Royer R.J., Steru L., Parot P. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol Alcohol. 30:1995;239-247.
175. Park E., Quinn M.R., Wright C.E., Schller Levis G. Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor necrosis factor in activated RAW264.7 cells. J. Leukoc. Biol. 54:1993;119-124.
176. Pasantes Morales H., Cruz C. Taurine and hypotaurine inhibit light-induced lipid peroxidation and protect rod outer segment structure. Brain Res. 330:1985;154-157.
177. Pasantes Morales H., Martin del Rio R. Taurine and mechanisms of cell volume regulation. Pasantes Morales H., Shain W., Martin del Rio R. Taurine: Functional Neurochemistry, Physiology and Cardiology. 1990;317-328 Wiley-Liss, New York.
178. Pasantes Morales H., Chacûn E., Sánchez Olea R., Morán J. Volume regulation in cultured neurons: pivotal role of taurine. Adv. exp. Med. Biol. 359:1994;317-323.
179. Pelc I., Verbanck P., Le Bon O., Gavrilovic M., Lion K., Lehert P. Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients - a 90-day placebo-controlled dose-finding study. Br. J. Psychiat. 171:1997;73-77.
180. 3H -GABA release in the hippocampus. Alcohol. clin. exp. Res. 21:1997;1047-1052.
181. Perkins K.L., Wong R.K.S. The depolarizing GABA response. Can. J. Physiol. Pharmac. 75:1997;516-519.
182. Peterson C., Neal J.H., Cotman C.W. Development of N-methyl-D-aspartate excitotoxicity in cultured hippocampal neurons. Dev. Brain Res. 48:1989;187-195.
183. Poldrugo F. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme. Addiction. 92:1997;1537-1546.
184. Putzke J., Spanagel R., Tolle T.R., Zieglgansberger W. The anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal. Eur. J. Pharmac. 317:1996;39-48.
185. Quertemont E., de Neuville J., De Witte Ph. Changes in the amygdala amino acid microdialysate after conditioning with a cue associated with ethanol. Psychopharmacology. 139:1998;71-78.
186. Quertemont E., Dahchour A., Ward R.J., De Witte Ph. Ethanol induces taurine release in the amygdala: an in vivo microdialysis study. Addiction Biol. 4:1999;47-54.
187. 35S] -t-butylbicyclophosphorothionate (TBPS) to rat brain synaptic membrane. Neuropharmacology. 34:1995;1607-1616.
188. Rassin D.K., Sturman J.A., Gaull G.E. Sulfur amino acid metabolism in the
189. Regan R.F., Choi D.W. Glutamate neurotoxicity in spinal cord cell culture. Neurosciences. 43:1991;585-591.
190. Riaz A., Faingold C.L. Seizures during ethanol withdrawal are blocked by focal microinjection of excitant amino acid antagonists into the inferior colliculus and pontine reticular formation. Alcohol. clin. exp. Res. 18:1994;1456-1462.
191. Ripley T.L., Little H.J. Nitrendipine prevents the decrease caused by chronic ethanol intake in the maintenance of tetanic long-term potentiation. Exp. Brain Res. 103:1995;1-8.
192. Roberts A.J., Koob G.F. The neurobiology of addiction: an overview. Alcohol Health Res. World. 17:1997;10-11.
193. Rossetti Z.L., Carboni S. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur. J. Pharmac. 283:1995;177-183.
194. A and NMDA receptor function in the rat brain. Alcohol. clin. exp. Res. 17:1993;115-123.
195. Saransaari P., Oja S.S. Taurine release from mouse hippocampal slices: effects of glutamergic substances and hypoxia. Huxtable R.J., Michalk D. Taurine in Health and Disease. 1994;279-287 Plenum Press, New York.
196. Saransaari P., Oja S.S. Enhanced taurine release in cell-damaging conditions in the developing and ageing mouse hippocampus. Neuroscience. 79:1997;847-854.
197. Sass H., Soyka M., Mann K., Zieglgansberger W. Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. Arch. Gen. Psychiat. 53:1996;673-680.
198. Schaffer S.W., Azuma J. Physiological effects of taurine in hearth. Lombardini J.B., Schaffer S.W., Azuma J. Nutritional Value and Mechanisms of Action. 1992;105-120 Plenum Press, New York.
199. Schaffer S.W., Azuma J., Madura J.D. Mechanisms underlying taurine-mediated alterations in membrane function. Amino Acids. 8:1995;231-246.
200. Scheibel J., Elsasser T., Ondo J.G. A neuromodulatory rol for taurine in contrilling prolactin secretion in female rats. Psychoneuroendocrinology. 6:1981;139-144.
201. Schoepfer R., Monyer H., Sommer B., Wisden W., Sprengel R., Kuner T., Lomeli H., Herb A., Kohler M., Burnashev N. Molecular biology of glutamate receptors. Prog. Neurobiol. 42:1994;353-357.
202. Schousboe A., Pasantes Morales H. Role of taurine in neural cell volume egulation. Can. J. Physiol. Pharmac. 70:1992;S356-S361.
203. Schuller Levis G., Quinn M.R., Wright C., Park E. Taurine protects against oxidant-induced lung injury: possible mechanism(s) of action. Huxtable R.J., Michalk D. Taurine in Health and Disease. 1994;31-39 Plenum Press, New York.
204. Shibanoki S., Kogure M., Sugahara M., Ishikawa K. Effect of systemic administration of N-methyl-D-aspartic acid on extracellular taurine level measured by microdialysis in the hippocampal CA1 field and striatum of rats. J. Neurochem. 61:1993;1698-1704.
205. Shimizu K., Matsubara K., Uezono T., Kimura K., Shiono H. Reduced dorsal hippocampal glutamate release significantly correlates with the spatial memory deficits produced by benzodiazepines and ethanol. Neuroscience. 83:1998;701-706.
206. - ion channels modulated by multiple drug-binding sites. Trends Pharmac. Sci. 13:1992;446-450.
207. A receptor subtypes. Pharmac. Rev. 47:1995;181-234.
208. Simson P.E., Criswell H.E., Johnson K.B., Hicks R.E., Breese G.R. Ethanol inhibits NMDA-evoked electrophysiological activity in vivo. J. Pharmac. exp. Ther. 257:1991;225-231.
209. Smith B.R., Amit Z., Splawinsky J. Conditioned place preference induced by intraventricular infusions of acetaldehyde. Alcohol. 1:1984;193-195.
210. Smothers C.T., Mrotek J.J., Lovinger D.M. Chronic ethanol exposure leads to a selective enhancement of N-methyl-D-aspartate receptor function in cultured hippocampal neurons. J. Pharmac. exp. Ther. 283:1997;1214-1222.
211. Snell L.D., Tabakoff B., Hoffman P.L. Radioligand binding to the N-methyl-D-aspartate receptor/ionophore complex: alterations by ethanol in vitro and by chronic in vivo ethanol ingestion. Brain Res. 602:1993;91-98.
212. Snell L.D., Nunley K.R., Lickteig R.L., Browning M.D., Tabakoff B., Hoffman P.L. Regional and subunit specific changes in NMDA receptor mRNA and immunoreactivity in mouse brain following chronic ethanol ingestion. Molec. Brain Res. 40:1996;71-78.
213. Solis J.M., Herranz A.S., Herreras O., Lerma J., Martin del Rio R. Does taurine act as an osmoregulatory substance in the rat brain? Neurosci. Lett. 15:1988;53-58.
214. Spanagel R., Holter S.M., Allingham K., Landgraf R., Zieglgansberger W. Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur. J. Pharmac. 305:1996;39-44.
215. Spanagel R., Sillaber I., Zieglgasberer W., Corrigall W.A., Stewart J., Shaham Y. Acamprosate suppresses the expression of morphine induced sensitization in rats but does not affect heroin self administration or relapse induced by heroin or stress. Psychopharmacology. 139:(4):1998;391-401.
216. Suzdak P.D., Glowa J.R., Crawley J.N., Schwartz R.D., Skolnick P., Paul S.M. A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science. 234:1986;1243-1247.
217. Thomas J.D., Weinert S.P., Sharif S., Riley E.P. MK-801 administration during ethanol withdrawal in neonatal rat pups attenuates ethanol-induced behavioral deficits. Alcohol. clin. exp. Res. 21:1997;1218-1225.
218. A receptor system in alcohol. Int. J. Neuropsychopharmac. 1:(suppl. 1):1998;S5.
219. Timbrell J.A., Seabra V., Waterfield C.J. The in vivo and in vitro protective properties of taurine. Gen. Pharmac. 26:1995;453-462.
220. Trachtman H., Futterweit S., Bienkowski R.S. Taurine prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Biochem. biophys. Res. Commun. 191:1993;759-765.
221. Tran G., Steru L., Daoust M., Parot P., Ladure P., Libert C., Boismare F. Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol Alcohol. 25:1990;613-622.
222. Trevisan L., Fitzgerald L.W., Brose N., Gasic G.P., Heinemann S.F., Duman R.S., Nestler R.J. Chronic ingestion of ethanol upregulates NMDAR1 receptor subunit immunoreactivity in rat hippocampus. J. Neurochem. 62:1994;1635-1638.
223. Trujillo K.A., Akil H. Excitatory amino acids and drugs of abuse: a role of NMDA receptors indrug tolerance, sensitization and physical dependence. Drug Alcohol Depend. 38:1995;139-154.
224. Tsai G.C., Coyle J.T. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. A. Rev. Med. 49:1998;173-184.
225. Tsai G.C., Gastfriend D.R., Coyle J.T. The glutamatergic basis of human alcoholism. Am. J. Psychiat. 152:1995;332-340.
226. - influx into cerebral membrane vesicles. Alcohol Alcohol. 26:1991;17-24.
227. Uusi Oukari M., Korpi E.R. Cerebellar GABAA receptor binding and function in vitro in two rat lines developed for high and low alcohol sensitivity. Neurochem. Res. 14:1989;733-739.
228. Uzbay I.T., Erden B.F., Tapanyigit E.E., Kayaalp S.O. Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sci. 61:1997;2197-2209.
229. Valnezuela C.F., Harris R.A. Alcohol: neurobiology. Lowinson J.H., Ruiz P., Millman R.B., Langrod J.G. Substance Abuse: A Comprehensive Textbook. 1997;119-142 Williams & Wilkins, Baltimore, MD.
230. Van den Pol A.N., Obrietan K., Chen G. Excitatory actions of GABA after neuronal trauma. J. Neurosci. 16:1996;4283-4292.
231. Vislobokov A.I., Mantsev V.V., Kopylov A.G., Gurevich V.S. Influence of taurine on the electrically regulated ionic channels of the somatic membrane of neurons of the pond snail. Neurosci. Behav. Physiol. 22:1992;315-319.
232. Wade J.V., Olson J.P., Samson F.E., Nelson S.R., Pazdernik T.L. A possible role for taurine in osmoregulation within the brain. J. Neurochem. 51:1988;740-745.
233. Ward R.J., Colantuoni C., Dahchour A., Quertemont E., De Witte Ph. Acetaldehyde-induced changes in the monoamine and amino acid extracellular microdialysate content of the nucleus accumbens. Neuropharmacology. 36:1997;225-232.
234. Watanabe A., Hobara N., Nagashima H. Lowering of liver acetaldehyde but not ethanol concentrations by pretreatment with taurine in ethanol-loaded rats. Experientia. 41:1985;1421-1422.
235. Waterfield C.J., Mesquita M., Parnham P., Timbrell J.A. Cytoprotective effects of taurine in isolated rat hepatocytes. Toxic. Vitro. 8:1994;573-575.
236. Weaver M.S., Lee Y.H., Morris J.L., Randall P.K., Schallert T., Leslie S.W. Effects of in vitro ethanol and fetal ethanol exposure on glutathione stimulation of N-methyl-D-aspartate receptor function. Alcohol. clin. exp. Res. 17:1993;643-650.
237. Weiner J.L., Zhang L., Carlen P.L. Potentiation of GABAA-mediated synaptic current by ethanol in hippocampal CA1 neurons: possible role of protein kinase C. J. Pharmac. exp. Ther. 268:1994;1388-1395.
238. Weiner J.L., Valenzuela C.F., Watson P.L., Frazier C.J., Dunwiddie T.V. Elevation of basal protein kinase C activity increases ethanol sensitivity of GABA(A) receptors in rat hippocampal CA1 pyramidal neurons. J. Neurochem. 68:1997;1949-1959.
239. Westbrook G.L. Glutamate receptor update. Curr. opin. Neurobiol. 4:1994;337-346.
240. White G., Lovinger D.M., Weight F.F. Ethanol inhibits NMDA-activated current but does not alter GABA-activated current in an isolated adult mammalian neuron. Brain Res. 507:1990;332-336.
241. Whittington M.A., Lambert J.D.C., Little H.J. Increased NMDA receptor and calcium channel activity underlying ethanol withdrawal hyperexcitability. Alcohol Alcohol. 30:1995;105-114.
242. Whitworth A.B., Fischer F., Lesch O.M., Nimmerrichter A., Oberbauer H., Platz T., Potgieter A., Walter H., Fleischhacher W.W. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet. 347:1996;1438-1442.
243. Williams M., Risley E.A., Totaro J.A. Interaction of taurine and beta-alanine with central nervous system neurotransmitter receptors. Life Sci. 26:1980;557.
244. Woodward J.J., Gonzales R.A. Ethanol inhibition of N-methyl-D-aspartate-stimulated endogenous dopamine release from rat striatal slices: reversal by glycine. J. Neurochem. 54:1990;712-715.
245. Wright C.E., Tallan H.H., Lin Y.Y., Gaull G.E. Taurine: biological update. A. Rev. Biochem. 55:1986;427-453.
246. Zeise M.L., Kasparov S., Capogna M., Zieglgansberger W. Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors. Eur. J. Pharmac. 231:1993;47-52.
247. Zieglgansberger W., Hauser C., Putzke J., Spanagel R., Wetzel C. The enhanced excitability of central neurons following chronic alcohol intake in reduced by acamprosate. Alcohol Alcohol. 30:1995;552.
248. Zhang Y., Crichton R.R., Boelaert J.R., Jorens P.G., Herman A.G., Ward R.J., Lallemand F., De Witte Ph. Decreased release of nitric oxide NO by alveolar macrophages after in vivo loading of rats with either iron or ethanol. Biochem. Pharmac. 55:1998;21-25.